Skip to main content
  • Poster presentation
  • Open access
  • Published:

P02.160. The psychosomatic model for clinical oncology


The studies suggested a psychodiagnosis of cancer patients according to the SPb regenerative pyramid model.


Thirty patients with lymphoma diseases, 30 patients with cancer of the reproductive organs (breast cancer and cervical cancer), and 39 patients with chronic myelogenous and lymphocytic leukemia were investigated.


The peculiarities of response to diseases in cancer patients were found according to the nosological group. It was shown that, despite the dominance of conventional adaptive ergopathic type of attitude to the disease (which is characterized by an obsessive attitude to work) in all studied groups, the presence of a high level of sensitivity component illustrates the lack of success to adapt to the situation of the disease. However, the presence of strong positive correlation between the type of response to disease and the level of depression in a group of hematological malignancies suggests a maladaptive system attitude to the disease in these patients. An analysis of coping behavior (by the method of Ways of Coping Checklist) of these categories of patients revealed a negative correlation between the level of depression and the most stressful coping strategies: seeking social support and positive reappraisal.


The obtained results have theoretical value in understanding the regularities of formation of coping behavior of patients with cancer pathology in different nosological groups.

Author information

Authors and Affiliations


Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Zhirkov, A., Stepanchuk, E. P02.160. The psychosomatic model for clinical oncology. BMC Complement Altern Med 12 (Suppl 1), P216 (2012).

Download citation

  • Published:

  • DOI: